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A b s t r a c t
Introduction: About 30% of patients with carotid artery stenosis (CAS) develop dementia after a cerebral ischemic event (CIE), 
and 20–50% suffer from CIE recurrence during 6 months. Carotid artery revascularization (CAR) may prevent CIE recurrence, at the 
cost of new microembolic lesions (MES). The impact of CAR on cognitive function is debatable.
Aim: To assess functional and cognitive outcome, cerebral flow on transcranial Doppler (TCD) and brain magnetic resonance 
imaging (MRI) in patients with symptomatic CAS referred for CAR.
Material and methods: Twenty-two patients (aged 69.0 ±7.2 y.o., 15 male) with recent CIE (21.9 ±20.9 days to CAR) related to 
CAS of mean 89.8 ±3.9% lumen reduction were prospectively evaluated with TCD, diffusion and perfusion MRI, Montreal Cognitive 
Assessment (MoCA), Mini Mental State Examination (MMSE), modified Rankin Scale (mRS) and the National Institutes of Health 
Stroke Scale (NIHSS) 24 h before, at 24–48 h and 1 month following CAR.
Results: New MES were found in 11 (50%) subjects following CAR. CAR resulted in a significant increase of cerebral flow velocity 
in the middle and anterior cerebral arteries (p < 0.002 and p = 0.003; respectively) and cerebral perfusion measured by time to peak 
(TTP) and mean transit time (MTT) (p = 0.0009 and p = 0.0002; respectively). Neurologic tests showed improvement in NIHSS (2.4 
±1.6 to 1.5 ±1.2, p = 0.003), mRS (from 1.3 ±0.9 to 0.7 ±0.9, p = 0.005), and MMSE (26.7 ±2.2 to 27.6 ±2.3, p = 0.019) at 1 month, 
while similar MoCA scores were observed before and 1 month after CAR (23.4 ±3.3 vs. 24.1 ±3.7, p = 0.136).
Conclusions: Improvement of cerebral flow and perfusion and functional outcome, as well as at least no cognitive decline, is 
observed after CAR for symptomatic CAS.
Key words: symptomatic carotid artery stenosis, microembolic ischemic lesions, cerebral perfusion, magnetic resonance, tran-
scranial color-coded Doppler, cognitive assessment.
Introduction
Carotid artery stenosis (CAS) plays an important role 
in cerebral ischemic event (CIE) incidence, e.g. ischemic 
stroke (IS) or transient ischemic accident (TIA), account-
ing for about 14% of all ISs according to the Oxford Vas-
cular Study [1]. About one third of patients develop cogni-
tive dementia following CIE [2], while 20–50% of subjects 
with symptomatic CAS suffer from CIE recurrence during 
6 months [2–4]. Furthermore, CAS frequently co-exists 
with arterial occlusive disease in other vital territories, 
which also impacts the cardiovascular prognosis in this 
group of subjects [5, 6]. 
According to current guidelines prompt carotid ar-
tery revascularization (CAR) is recommended in patients 
with CAS exceeding 50% lumen reduction, preferably 
within 2 weeks following CIE [7, 8]. This approach is as-
sociated with 33% recurrent CIE risk reduction for inter-
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ventional treatment as compared to the optimal medical 
approach [1].
Cerebral perfusion improvement seems a reasonable 
consequence of the restored cerebral flow after CAR, and 
this theoretically should be associated with an improve-
ment in cognitive and functional status. Indeed, some 
researchers emphasize the role of cerebral perfusion 
improvement following CAR as a  predictor of cognitive 
outcome [9].
However, the procedure either with carotid artery 
stenting (PTA) or carotid endarterectomy (CEA) may be 
potentially associated with further cognitive function 
decline, which may be attributed to new acute microem-
bolic lesions (MES), noted on brain diffusion-weighted 
magnetic resonance imaging (DWI-MRI) or periprocedur-
al transcranial color-coded duplex Doppler (TCD) moni-
toring [10–12]. On the other hand, some studies do not 
support the relationship between MES and cognitive 
function decline [9, 13]. Moreover, according to some 
studies there is no association between periprocedural 
MES and cerebral perfusion [14–16].
Aim
This present study, covering a variety of aspects con-
cerning the outcome of CAR either by CEA or by PTA, was 
aimed to assess functional and cognitive outcome, with 
regard to cerebral flow on TCD and DWI-MRI in patients 
with recently symptomatic CAS.
Material and methods
The study included 22 consecutive patients, (mean 
age: 69 ±7.2 y.o., 15 male) with recent CIE (21.9 ±20.9 
days to CAR, range: 5–89) defined as first IS or TIA, re-
lated to severe CAS (mean stenosis degree: 89.8 ±3.9%, 
range: 80–99%), who were admitted to the Vascular and 
Endovascular Surgery Department between September 
2015 and January 2017 with the aim of CAR.
The eligibility criteria were as follows: first CIE, uni-
lateral, symptomatic CAS > 70%, measured with carotid 
Duplex ultrasound, using the NASCET criteria, history of 
IS or TIA within 60 days prior to CAR.
The exclusion criteria were as follows: history of for-
mer CIE, patients with bilateral CAS, including contra-
lateral carotid artery occlusion, known other potential 
causes of CIE (atrial fibrillation, patent foramen ovale, 
cerebral artery aneurysms/malformations), non-diagnos-
tic temporal window for TCD, contraindications for MRI, 
known prior advanced dementia with Mini-Mental State 
Examination (MMSE) score below 20 and Montreal Cog-
nitive Assessment Scale (MoCA) score below 14.
Each patient signed an informed consent form be-
fore the revascularization procedure. The study was 
performed according to the institutional bioethics com-
mittee and was performed in accordance with the Decla-
ration of Helsinki.
At baseline, demographic data, presented symptoms, 
medical characteristics as well as cardiovascular risk fac-
tors (such as hypertension, hypercholesterolemia, diabetes 
mellitus, or active smoking) were collected from each pa-
tient. The obtained information included age, gender, his-
tory of coronary artery disease (CAD), myocardial infarction 
(MI), history of coronary revascularization (both PCI and 
CABG), as well as interventions within peripheral arteries.
The qualifying IS or TIA was based on the consultant 
neurologist’s opinion, and sourced from medical docu-
mentation and obtained brain imaging either with com-
puted tomography (CT) or MRI. 
Internal carotid artery revascularization
The patients admitted to the department were referred 
for PTA or CEA depending on the Vascular Team multidis-
ciplinary decision, including the consultant neurologist. Ca-
rotid artery angiography was performed before CAR with 
the measurement of internal carotid artery lumen reduc-
tion using quantitative assessment (Siemens, Coroscop, 
Enlargen, Germany). The PTA was performed according to 
Tailored-CAS criteria, with a proximal or distal neuroprotec-
tion system in patients treated with dual antiplatelet ther-
apy [17]. Stent and neuroprotection system selection was 
made according to degree of stenosis, plaque morphology 
and collateral cerebral flow [17]. The CEA was performed 
on a single antiplatelet agent and periprocedural heparin. 
The procedure technique choice was left at the discretion 
of the operating surgeon. All CEAs were performed with 
eversion technique and periprocedural shunt.
Carotid ultrasonography
The severity of CAS was assessed by high-resolution 
B-mode, color Doppler and pulse Doppler ultrasonography 
of extracranial arteries and was performed with an ultra-
sound machine (Toshiba Aplio TUS-A300; Saronno, Italy) 
fitted with a  linear-array 7.5 MHz transducer. Patients 
were examined in a supine position with the head tilted 
backwards. In compliance with the Carpenter criteria [18], 
the grade of stenosis in carotid arteries was assessed by 
measuring the increase in the peak systolic velocity (PSV) 
> 2.1 m/s and the end-diastolic velocity (EDV) > 0.7 m/s. 
Carotid plaque morphology was classified in accordance 
with Gray-Weale criteria [19], in brief: four plaque types 
were defined based on their degree of echolucency as-
sessed in B-mode view: type 1: predominantly echolu-
cent, type 2: intermediate echolucent lesions with small 
areas of echogenicity, type 3: intermediate echogenic le-
sions with small areas of echolucency, type 4: uniformly 
echogenic lesions. Furthermore, the plaque surface was 
described as either smooth, irregular or ulcerated.
Transcranial color-coded duplex Doppler
Following the carotid ultrasound, every patient had 
a  TCD examination performed through the temporal 
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approach. Examination of intracranial arteries was per-
formed with a Toshiba Aplio TUS-A300; (Saronno, Italy) 
machine fitted with a  sector-array 1.5–2.5 MHz trans-
ducer. TCD examination included measurements of PSV 
and EDV in the first segments of cerebral arteries within 
the circle of Willis: ipsilateral to stenosed ICA in middle 
(MCA), and anterior (ACA) cerebral arteries, as well as 
contralateral MCA and ACA.
Furthermore, the flow directions and functions of an-
terior (ACoA) and posterior (PCoA) communicating arter-
ies were assessed. The ACoA was assessed as present 
when the same flow directions in the ipsilateral MCA and 
ACA were observed. PCoA was assessed as present when 
the blood flow between the trifurcation and ipsilateral 
posterior cerebral artery (P1/P2 segment) was recorded 
on TCD [20]. All scans were obtained by the same expe-
rienced sonographer who had no prior knowledge of the 
subjects’ clinical and angiographic characteristics.
Both carotid ultrasound and TCD were performed 
1 day prior to CAR, at 24–48 h after CAR and 4 weeks 
following CAR. 
Magnetic resonance imaging
To assess cerebral perfusion, magnetic resonance 
scans were obtained 1 day prior to CAR, at 24–48 h after 
CAR and 4 weeks following CAR. 
The imaging was performed with a  1.5 T scanner 
(Magnetom Sonata Maestro Class, Erlangen, Germany), 
using a  dedicated 8-element head coil. The protocol 
covered the DWI as well as perfusion-weighted imaging 
(PWI) with cerebral blood volume (CBV), cerebral blood 
flow (CBF), time to peak (TTP), and mean transit time 
(MTT), calculated upon acquired images. The scanning 
protocols included T1-weighted images, T2-weighted im-
ages and FLAIR images. Dynamic susceptibility contrast 
(DSC) MRI is also known as PWI. 
On DWI imaging 24–48 h after CAR any new detect-
able lesions within both hemispheres, not visualized in 
the study prior to CAR, were considered as MES. The total 
number of lesions and maximal diameter were calculat-
ed manually by a qualified radiologist.
The PWI data were acquired using T2*-weighted im-
aging by a gradient echo-planar sequence with the first 
passage of contrast bolus in brain tissues, after intrave-
nous injection of a standard dose of 0.05 mmol/kg body 
weight of gadolinium-based contrast agent with the flow 
of 5 ml/s followed by a bolus of 20 ml saline (0.9% NaCl) 
with the same flow (5 ml/s) using an automatic power 
injector. During the first pass of gadolinium-based con-
trast agent it is confined in the vasculature and produces 
local magnetic field gradients that induce a decrease in 
the signal of T2*-weighted images (susceptibility effects). 
These susceptibility effects are seen as a transient signal 
loss in the tissue of interest on T2*-weighted imaging.
Using commercially available software, various func-
tional parameters and maps of TTP and MTT were calcu-
lated from the time-signal intensity curves measured in 
each pixel. Maps can be interpreted visually or quantita-
tively by calculating the relative values. The range of val-
ues of each perfusion parameter is demarcated by a col-
or scale, usually with the color red indicating the highest 
values and blue representing the lowest values.
The regions of interest were set manually within the 
area of MCA parallel in both hemispheres as well as with-
in the venous sinus. The assessment was made before 
CAR, 24–48 h after CAR and after 4 weeks of follow-up 
for the ipsilateral hemisphere. The mean values of MTT 
and TTP were calculated for each patient separately in 
each study. 
Cognitive function
Cognitive function of the study participants was as-
sessed with Montreal Cognitive Assessment (MoCA) [21, 
22] and Mini Mental State Examination (MMSE) [23] 
scales, prior to CAR, 24–48 h after CAR and after 1-month 
of follow-up. The exclusion criteria were the cut-off score 
values equal to or below 20 and 14 for MMSE and MoCA, 
respectively, as suggesting severe dementia.
Functional status
Functional outcome was estimated using the modi-
fied Rankin Scale (mRS) and National Institutes of Health 
Stroke Scale (NIHSS) at 24 h before CAR, at 24–48 h after 
and at 1 month following CAR [24, 25].
Statistical analysis
Continuous variables are presented as mean ± one 
SD, categorical variables are expressed as frequen-
cies and percentages. Means of analyzed parameters 
across groups were tested with the analysis of variance 
(ANOVA) test, and frequencies were compared by the c2 
test for independence. The non-parametric Mann-Whitney 
U test was used to determine differences in peak-systol-
ic flow velocities recorded in the corresponding cerebral 
arteries among the studied group of patients as well as 
the differences in neuropsychological and functional 
tests’ outcomes. The non-parametric Wilcoxon test for 
dependent samples was performed to assess the differ-
ences in PWI parameters: MTT and TTP in studies per-
formed before and after CAR, the associations between 
PWI parameter changes and new MES following CAR, as 
well as the change in neuropsychological tests’ outcomes 
before and after CAR. The correlation between brain PWI 
assessment (TTP and MTT values) on MRI and cerebral 
flow on TCD, as well as the correlation between appear-
ance of new, acute MES following CAR and improvement 
of PWI parameters and neurocognitive test results, was 
calculated with the non-parametric Spearman’s rank-or-
der test. Statistical analyses were performed with Statis-
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tica 12.0 software. Statistical significance was assumed 
at p < 0.05.
Results
Baseline characteristics of study participants are 
shown in Table I.
Upon assessment of carotid plaque morphology, the 
majority of plaques observed in study participants were 
considered high risk (type I and II), as evidenced by ul-
trasonography and post-CAR histological assessment of 
plaques (Table I).
The PTA was performed in 17 (77.3%), CEA in 5 (22.7%) 
subjects (Table II). Periprocedural 30-day complications 
occurred in 3 (13.6%) subjects, including 2 (9.0%) CIE 
(NIHSS 5, mRS 3 and NIHSS 2, mRS 1 respectively) af-
ter PTA observed within 24 h following CAR, the first one 
presenting with moderate motoric aphasia, which dimin-
ished significantly on examination after 1 month of fol-
low-up, the second one with mild left upper limb paresis, 
as well as atrial fibrillation in 1 patient after CEA with no 
further clinical consequences. No periprocedural deaths, 
MI, major IS or TIA were noted.
Diffusion-weighted magnetic resonance imaging
Acute and subacute multiple cerebral ischemic le-
sions were observed on DWI-MRI in all subjects before 
CAR (mean lesion size of 17 ±14.9 mm, range: 4–58 mm). 
Two patients suffered from periprocedural CIE. One 
had multiple ischemic lesions of maximum 24 mm in 
the left hemisphere with moderate motoric aphasia 
(NIHSS = 5). At 4 weeks following CAR, the lesion de-
creased to 19 mm. The second one had isolated ischemic 
lesions of maximum 69  mm with mild left upper limb 
paresis (NIHSS = 2).
After CAR, DWI-MRI post-procedurally was contraindi-
cated in 1 subject due to placement of the metal sternal 
clips.
In the remaining 18 uncomplicated patients, new 
MES were found in 9 (47.4%) on 24–48 h DWI-MRI ex-
amination following CAR (Table III). In these subjects, the 
mean number of MES was 3.0 ±2.4 (range: 1–9), with 
the mean lesion size of 4.3 ±2.2 mm (range: 3–8 mm). 
Of those, in 2 (22.2%) patients MES resolved completely, 
while in 6 (66.7%) patients MES decreased on DWI-MRI 
at 1 month after CAR.
Table I. Clinical characteristics of study participants
Parameter Value
Number of patients 22
Age 69.0 ±7.2, range: 56–81
Male gender 15 (68.2%)
Hypertension 22 (100%)
Diabetes mellitus 6 (27.3%)
Hyperlipidemia 21 (95.5%)
Cigarette smoking – current or former 7 (31.8%)
Coronary artery disease* 13 (59.1%)
History of myocardial infarction 1 (4.5%)
History of PCI 3 (13.6%)
History of CABG 1 (4.5%)
Peripheral arterial disease 6 (27.3%)
Grade of ICAS before CAR** 89.8 ±3.9%,  
range: 80–99%
String stenosis 7 (31.8%)
Plaque morphology:
Type 1: Predominantly echolucent 5 (22.7%)
Type 2: Intermediate echolucent 10 (45.5%)
Type 3: Intermediate echogenic 5 (22.7%)
Type 4: Uniformly echogenic 2 (9.1%)
Ulceration 14 (63.6%)
Histopathological assessment:
Thrombotic 4 (18.2%)
Lipid rich 7 (31.8%)
Fibrotic 4 (18.2%)
Heterogeneous 5 (22.7%)
Calcified 2 (9.1%)
*Significant coronary artery stenosis exceeding 50% lumen reduction on coro-
nary angiography, **according to NASCET criteria.
Table II. Details of CAR procedure techniques per-
formed in presented subjects
Parameter Value
CAR 22
Carotid artery stenting 17 (77.3%)
Neuroprotection system:
Distal 9 (52.9%)
Proximal 8 (47.1%)
Stent type:
C-Guard 5 (29.4%)
RoadSaver 5 (29.4%)
Carotid Wallstent 4 (23.5%)
Cristallo 2 (11.8%)
Xact 1 (5.9%)
Direct stenting 4 (23.5%)
Predilatation 13 (76.5%)
CEA 5 (22.7%)
Eversion 5 (100%)
Shunt 5 (100%)
CAR – carotid artery revascularization, CEA – carotid endarterectomy.
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Thus, MES occurred in 1 out of 5 (20%) patients after 
CEA, and 8 out of 14 (57%) subjects after PTA. The mean 
diameter of MES after CEA was 4 mm and after PTA 3.9 
±2.3, range: 1–8 mm.
After 1 month, among all patients cerebral ischemic 
lesions persisted in 6 (27.3%), resolved in 3 (13.6%), de-
creased in 12 (54.5%) and progressed in 1 (4.5%) patient. 
Perfusion-weighted imaging magnetic 
resonance imaging
Prior to CAR, perfusion in the hemisphere ipsilateral 
to CAS was significantly impaired, as compared to the 
contralateral hemisphere, as evidenced by longer TTP 
(35.5 ±4.3 vs. 35.0 ±4.5 s, p = 0.042). As for MTT, the re-
sults failed to reach statistical significance (22.4 ±3.5 vs. 
21.3 ±4.3 s, p = 0.155).
At 1 month following CAR, PWI-MRI showed improve-
ment of cerebral perfusion in the hemisphere supplied by 
the revascularized ICA, resulting in similar TTP and MTT 
parameters in both hemispheres (32.5 ±3.8 vs. 32.7 ±3.6 s; 
p = 0.783 and 17.9 ±3.3 vs. 18.7 ±3.7 s; p = 0.055 respec-
tively).
At 1 month, there was a significant improvement in 
cerebral PWI in all subjects, expressed as shortening of 
passage times for TTP (from mean 36.1 ±4.2 to 32.6 ±3.9; 
p = 0.0009, range: –1.5 to –11.9 s) and for MTT (from 
mean 22.8 ±3.4 to 17.8 ±3.4; p = 0.0002; range: –1.5 to 
–10.8 s), as compared to pre-procedural values. There 
was no statistical difference in brain perfusion improve-
ment measured by MTT and TTP in patients with and 
without new, acute MES in brain DWI (Table III).
Transcranial color-coded duplex Doppler
Both 24–48 h after CAR and at 1 month following CAR, 
there was a significant increase of cerebral flow velocity at 
the site of the procedure as compared to the examination 
performed prior to revascularization: in the MCA from 75 
±19.7 to 117 ±33.8 and to 98 ±22.7 cm/s, p = 0.001, re-
spectively and in the ACA from 76 ±25.9 to 101 ±30.0 and 
to 87 ±20.2 cm/s, p = 0.021; respectively, Table IV. 
The flow increase seen on TCD was not correlat-
ed with cerebral perfusion increase seen on PWI-MRI. 
The difference between post-procedural velocities and 
pre-procedural velocities in the MCA was not correlated 
with change in either TTP or MTT, both at 24–48 h and 
1 month following CAR (p = NS).
Functional and cognitive outcome
Improvement of cognitive function was found in 16 
(72.7%) by MMSE and in 14 (63.6%) subjects by MoCA 
at 1 month following CAR. MMSE scores were: 26.7 
±2.2, 27.4 ±2.0 and 27.6 ±2.3 before, at 24–48 h and at 
4 weeks following CAR, respectively, meaning that there 
was a  significant improvement of cognitive function 
4 weeks after CAR as compared to pre-procedural assess-
ment (p = 0.019). 
The MoCA scores were 23.4 ±3.3, 23.9 ±3.1 and 24.1 
±3.7 before, at 24–48 h and at 4 weeks following CAR 
respectively, with no significant difference between the 
respective examinations (p = 0.136), which means no 
cognitive decline assessed by MoCA, despite the lack of 
statistically significant improvement. There was no cor-
relation between the improvement of cerebral perfusion 
and improvement of MMSE and MoCA results.
Functional outcome, measured with NIHSS and mRS, 
significantly improved 4 weeks after CAR from 2.3 ±1.6 
to 1.4 ±1.2 (p = 0.012) and from 1.2 ±0.9 to 0.7 ±0.9 
(p = 0.012), respectively (Table IV). In 7 patients NIHSS 
and in 9 patients mRS remained unchanged. New MES 
were not associated with cognitive function outcome or 
cerebral perfusion at 1 month after CAR as compared to 
pre-procedural values (Table III). 
Table III. Comparison of functional and cognitive status, as well as cerebral perfusion at 1 month in patients 
with and without MES at 24–48 h following CAR
Variable Subjects with acute MES  
after CAR
(n = 9)
Subjects without acute MES  
after CAR
(n = 10)
P-value
NIHSS change before vs. 1 month after CAR –0.8 ±0.9 –1.1 ±1.0 0.505
mRS change before vs. 1 month after CAR –0.4 ±0.5 –0.6 ±0.5 0.450
MMSE change before vs. 1 month after CAR 1.0 ±1.5 0.9 ±1.9 0.902
MoCA change before vs. 1 month after CAR 0.3 ±2.3 1.5 ±2.8 0.437
TTP change before vs. 1 month after CAR –3.51 ±2.63 –3.72 ±4.21 0.911
MTT change before vs. 1 month after CAR –6.35 ±2.51 –3.42 ±3.11 0.112
TTP – time to peak, MTT – mean transit time, MMSE – Mini-Mental State Examination, MoCA – Montreal Cognitive Assessment, NIHSS – National Institute of Health 
Stroke Scale, mRS – modified Rankin Scale. 
*One patient had no DWI-MRI after CAR due to sternal metal clips; in 2 patients PTA was complicated by minor IS with new ischemic lesions on brain MRI. Data are 
presented as the difference between pre-procedural and 1-month follow-up values.
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Discussion
In this preliminary study concerning a  variety of 
factors that may potentially impact the result of CAR 
in patients after first in their lifetime CIE, we observed 
the immediate improvement of cerebral flow in terms 
of the velocity increase in MCA and ACA in the circle of 
Willis, and cerebral perfusion, as well as a  significantly 
improved functional outcome in all subjects.
In the light of the CIE recurrence rate as well as high 
1-year mortality and disability rate, accounting for up to 
50%, 20% and 30–40% , respectively, urgent intervention 
for CAS seems highly justified [4, 7].
We would like to emphasize several aspects of CIE relat-
ed to CAS. As evidenced by others, and also observed in the 
present study, the majority of symptomatic patients have 
carotid plaque morphology which could be called a vulner-
able plaque [19]. In subjects with CIE due to CAS, echolu-
cent plaques accounted for 71% of all plaques identified, 
ulcerated in 67%. Several studies have already confirmed 
that hypoechogenic, echolucent carotid plaques increase 
the risk of CIE in patients with CAS and can be a viable pre-
dictor of prevalence of future CIE in those patients [26–29]. 
Furthermore, the collateral cerebral circulation is 
less prevalent in recently symptomatic patients as com-
pared to asymptomatic with CAS and was observed in 
12 (57.1%) of 21 study participants. These findings are 
in line with our former study on 371 patients, in which 
the collateral flow within the circle of Willis as observed 
by TCD was present in 67% of patients with recent CIE 
[20]. Similarly, in the preliminary study by Ito et al., on 
12 subjects, the presence of the ACoA and PCoA on dy-
namic magnetic resonance angiography was observed in 
42% and 17% of symptomatic patients with CAS > 70%, 
respectively [30]. 
Our study demonstrated that cerebral perfusion on 
PWI-MRI prior to CAR was significantly impaired within 
the hemisphere supplied by the stenotic ICA. Following 
CAR, we observed similar PWI parameters in both hemi-
spheres. There are limited data concerning this aspect 
of CAR in the available literature. Piñero et al. observed 
significantly increased TTP in all patients prior to PTA in 
the affected hemisphere in comparison to the contralat-
eral hemisphere (p = 0.007) [31]. Similar to our study, 
normalization of cerebral perfusion was observed for TTP 
1 month after PTA in all patients [31].
What is more, cerebral perfusion improved signifi-
cantly in both hemispheres, which was expressed by the 
shortening of TTP and MTT bilaterally. A similar outcome 
in regard to TTP measured briefly after CAR was noted in 
most, but not all, patients in the study by Gauvrit et al. 
[32], as well as Tavares et al. [33] and Wang et al. [34].
After CAR, there was an immediate increase in the 
flow velocities in the ipsilateral MCA and ACA observed 
in the TCD study 24–48 h following the procedure, which 
stabilized in the study after 4 weeks of follow-up. Those 
findings correspond well with another study on 92 pa-
tients, which found a significant PSV increase by 26% in 
the MCA and by 30% in the ACA measured by TCD 24 h 
after PTA as compared to examination prior to CAR [35]. 
These results are also in line with available studies con-
Table IV. Cognitive and functional outcome as well as cerebral perfusion in TCD and brain MRI before, 24–48 h 
after and 1 month after CAR in patients with symptomatic carotid artery stenosis
Variable Before CAR 24–48 h after CAR After 4-week follow-up P-value
TCD:
iMCA PSV [cm/s] 75 ±19.7 117 ±33.8 98 ±22.7 0.001
iACA PSV 76 ±25.9 101 ±30.0 87 ±20.2 0.021
cMCA PSV 122 ±34.0 119 ±23.8 106 ±22.9 0.026
cACA PSV 125 ±38.9 96 ±22.2 88 ±23.9 0.005
Functional status:
NIHSS 2.3 ±1.6 2.3 ±1.7 1.4 ±1.2 0.003
mRS 1.2 ±0.9 1.3 ±1.0 0.7 ±0.9 0.005
Cognitive function:
MMSE 26.7 ±2.2 27.4 ±2.0 27.6 ±2.3 0.019
MoCA 23.4 ±3.3 23.9 ±3.1 24.1 ±3.7 0.136
PWI:
TTP 35.5 ±4.3 35.5 ±4.2 32.5 ±3.8 0.0009
MTT 22.4 ±3.5 19.6 ±4.2 17.9 ±3.3 0.0002
TTP – time to peak, MTT – mean transit time, MMSE – Mini-Mental State Examination, MoCA – Montreal Cognitive Assessment, NIHSS – National Institute of Health 
Stroke Scale, mRS – modified Rankin Scale, TCD – transcranial color-coded duplex Doppler, MCA – middle cerebral artery, ACA – anterior cerebral artery.
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firming the improvement of circle of Willis flow by either 
TCD or MRI examination [36, 37].
In our study, the increase of brain perfusion was fol-
lowed by the improvement of functional outcome and 
cognitive functions. Concordantly, in the study by Wang 
et al. [34] concerning 46 patients treated with CEA, PWI 
improvement after CAR was correlated with the improve-
ment in MoCA (20.5 ±1.7 vs. 22.0 ±1.5, p = 0.001) with 
a linear correlation between TTP and MoCA (R = –0.893, 
p < 0.001). In our study there was a statistically signif-
icant improvement in MMSE (26.5 ±2.2 vs. 27.9 ±2.0, 
p = 0.014), but not in MoCA (23.2 ±3.2, vs. 24.3 ±3.2, 
p = 0.171). In the only available, preliminary study on 
20 patients, concerning the effect of PTA on perfusion 
and cognitive outcome, the improvement of brain per-
fusion was a strong predictor of cognitive improvement 
(p = 0.04) [38].
The inevitable consequence of CAR is MES, which 
are more evident after PTA as compared to CEA. It is still 
open for discussion whether, and to what degree, new 
MES impact cognitive function, functional status and 
brain perfusion. 
In our study, there was no association between new 
MES in DWI-MRI and cognitive and functional status. The 
incidence of new MES observed in DWI-MRI 24–48 h af-
ter PTA was 7/13 (54%), while after CEA it was 1/5 (20%), 
which is consistent with the available literature [13–16, 
39, 40]. 
However, despite the fact that 40.9% of our patients 
had evidence of new MES on DWI-MRI, this finding was 
not associated with poorer functional and cognitive 
outcome, and it did not have an impact on the cerebral 
perfusion improvement. It is worth mentioning that, in 
our study, MES were small in size. Furthermore, in 15% 
of subjects, MES resolved after 1 month, while in the 
remaining 52% they decreased significantly. Similarly, 
Grunwald et al. reported that the presence of DWI lesions 
did not affect the neuropsychological change, and PTA it-
self did not lead to cognitive decline [13]. Those findings 
suggest that although CAR is associated with the acute 
procedure-related MES, they do not clearly contribute to 
cognitive deprivation or dementia [13].
In contrast, in the study by Maggio et al. [15], the 
lesion incidence on DWI-MRI in patients after PTA was 
24% and the incidence of new MES after PTA was as-
sociated with a  significant decrease of cognitive out-
come assessed by MMSE: mean MMSE reduction of –3.1 
(95% CI ranging from –5.8 to –0.5) in patients with new 
MES after CAR, as compared to mean MMSE change of +1.1 
(95% CI from –0.3 to +2.5) in the group with no new le-
sions [15]. Similar findings can be found in the paper by 
Zhou et al. [16], in which the multivariate regression anal-
ysis revealed that MES observed after CAR were associat-
ed with memory decline (p = 0.016) and overall cognitive 
deterioration in MMSE (p = 0.026) [16]. 
To summarize, our findings, as well as available data, 
indicate that early revascularization after CIE seems to 
have a beneficial effect on cerebral perfusion, functional 
status and cognitive function, despite the fact that the 
revascularization procedure carries the risk of periproce-
dural microembolisation.
Conclusions
This preliminary study concerning many aspects of 
CAR following CIE indicated immediate improvement of 
cerebral flow seen on TCD and brain perfusion in PWI 
MRI. However, in our study no correlation was observed 
between the improvement of brain perfusion in PWI-MRI 
and cerebral flow in TCD examination. We observed an 
improvement in cognitive function in about 2/3 of pa-
tients, as well as in the functional status in the majority 
of our patients. Our study also demonstrated no correla-
tion between cognitive function changes and new MES 
after carotid revascularization. Larger, preferably multi-
center studies are necessary to elucidate the association 
between cognitive function, functional status and brain 
perfusion.
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